• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Population immunity and vaccine protection against infection.

作者信息

Leshem Eyal, Lopman Benjamin Alan

机构信息

Infectious Diseases Unit, The Chaim Sheba Medical Centre, Ramat-Gan 52621, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Rollins School of Public Health, Emory University, Atlanta, GA, USA.

出版信息

Lancet. 2021 May 8;397(10286):1685-1687. doi: 10.1016/S0140-6736(21)00870-9. Epub 2021 Apr 23.

DOI:10.1016/S0140-6736(21)00870-9
PMID:33901422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064666/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f0/8064666/bfd948b31a17/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f0/8064666/bfd948b31a17/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f0/8064666/bfd948b31a17/fx1_lrg.jpg

相似文献

1
Population immunity and vaccine protection against infection.群体免疫与疫苗对感染的防护作用。
Lancet. 2021 May 8;397(10286):1685-1687. doi: 10.1016/S0140-6736(21)00870-9. Epub 2021 Apr 23.
2
Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.高龄人群针对人呼吸道合胞病毒感染的疫苗接种免疫反应受损。
J Virol. 2014 Sep 1;88(17):9744-50. doi: 10.1128/JVI.01101-14. Epub 2014 Jun 11.
3
Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.用实验场特异性和商业 PRRSV 疫苗对 PRRSV 免疫母猪进行加强免疫后的抗体反应和母源免疫力。
Vet Microbiol. 2013 Dec 27;167(3-4):260-71. doi: 10.1016/j.vetmic.2013.08.017. Epub 2013 Aug 28.
4
Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.用于诱导持久体液免疫介导的对小鼠流感广泛保护的鼻内腺病毒载体疫苗。
J Virol. 2014 Sep 1;88(17):9693-703. doi: 10.1128/JVI.00823-14. Epub 2014 Jun 11.
5
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.使用病毒刺突蛋白DNA和蛋白质进行初免-加强免疫接种对中东呼吸综合征冠状病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01176-20.
6
A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.编码伪狂犬病病毒（猪疱疹病毒1型）gB和gD的DNA疫苗在存在母源免疫力的情况下比传统疫苗更有效地激发免疫系统。
Vaccine. 2006 Feb 27;24(9):1264-73. doi: 10.1016/j.vaccine.2005.09.041. Epub 2005 Oct 3.
7
Nucleoside-Modified mRNA Vaccines Protect IFNAR Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.核苷修饰的 mRNA 疫苗可保护 IFNAR 小鼠免受克里米亚-刚果出血热病毒感染。
J Virol. 2022 Feb 9;96(3):e0156821. doi: 10.1128/JVI.01568-21. Epub 2021 Nov 24.
8
Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs.疫苗接种途径和DNA疫苗组成对猪伪狂犬病感染诱导保护性免疫的影响。
Vet Immunol Immunopathol. 1998 Nov 24;66(2):113-26. doi: 10.1016/s0165-2427(98)00186-x.
9
Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.牛传染性口蹄疫（FMD）腺病毒载体亚单位疫苗诱导的保护持续时间和体液免疫。
Vaccine. 2019 Sep 30;37(42):6221-6231. doi: 10.1016/j.vaccine.2019.08.017. Epub 2019 Sep 5.
10
Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.生成 DelNS1 流感病毒：优化活流感疫苗的策略。
mBio. 2019 Sep 17;10(5):e02180-19. doi: 10.1128/mBio.02180-19.

引用本文的文献

1
Primary Healthcare Providers' Views on Periodic COVID-19 Booster Vaccination for Themselves and Their Patients: A 2023 Nationwide Survey in Belgium.基层医疗服务提供者对自身及患者定期接种新冠病毒加强针的看法：2023年比利时全国性调查
Vaccines (Basel). 2024 Jul 3;12(7):740. doi: 10.3390/vaccines12070740.
2
Clinical Characteristics of Children Infected with SARS-CoV-2 Omicron (B.1.1.529) in China's Shanghai.中国上海感染新型冠状病毒奥密克戎变异株（B.1.1.529）儿童的临床特征
Int J Gen Med. 2024 Jan 23;17:245-251. doi: 10.2147/IJGM.S429870. eCollection 2024.
3
Vaccination against COVID-19 and socioeconomic inequalities: A cross-sectional study in Ecuador.

本文引用的文献

1
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.英格兰医护人员的 COVID-19 疫苗接种率和 BNT162b2 mRNA 疫苗对感染的有效性（SIREN）：一项前瞻性、多中心、队列研究。
Lancet. 2021 May 8;397(10286):1725-1735. doi: 10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23.
2
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.BNT162b2 疫苗和 mRNA-1273 新冠疫苗在预防医护人员、第一响应者和其他必要及一线工作人员感染 SARS-CoV-2 中的疫苗有效性的临时估计-2020 年 12 月至 2021 年 3 月美国 8 个地点。
MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3.
3
2019冠状病毒病疫苗接种与社会经济不平等：厄瓜多尔的一项横断面研究
Vaccine X. 2023 Sep 20;15:100393. doi: 10.1016/j.jvacx.2023.100393. eCollection 2023 Dec.
4
[Validation of COVID-19 vaccines administered abroad: experience and challenges of implementation in ChileRegistro de vacinação contra a COVID-19: experiência e desafios relacionados com a implementação no Chile].[在国外接种的新冠疫苗验证：智利的实施经验与挑战 新冠疫苗接种登记：智利实施过程中的经验与挑战]
Rev Panam Salud Publica. 2023 Apr 14;47:e62. doi: 10.26633/RPSP.2023.62. eCollection 2023.
5
A comparative study of eight COVID-19 protective measures and their impact on Swiss tourists' travel intentions.八项新冠疫情防护措施及其对瑞士游客旅行意愿影响的比较研究。
Tour Manag. 2023 Aug;97:104734. doi: 10.1016/j.tourman.2023.104734. Epub 2023 Jan 25.
6
Megastudies: A New Approach to Reducing Vaccine Hesitation Worldwide.大型研究：一种在全球范围内减少疫苗犹豫的新方法。
Vaccines (Basel). 2023 Jan 6;11(1):133. doi: 10.3390/vaccines11010133.
7
Changes in Social and Clinical Determinants of COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study.疫苗接种计划对 COVID-19 结局的社会和临床决定因素的改变：一项全国性队列研究。
Int J Environ Res Public Health. 2022 Oct 5;19(19):12746. doi: 10.3390/ijerph191912746.
8
Safe reopening of university campuses is possible with COVID-19 vaccination.新冠疫苗接种可实现大学校园安全重开。
PLoS One. 2022 Jul 21;17(7):e0270106. doi: 10.1371/journal.pone.0270106. eCollection 2022.
9
Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults.新冠病毒疫苗和既往感染对年轻人任何 SARS-CoV-2 感染的有效性和保护持续时间。
Nat Commun. 2022 Jul 8;13(1):3946. doi: 10.1038/s41467-022-31469-z.
10
COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants.COVID-19疫苗接种策略及其对SARS-CoV-2变体出现的适应性
Vaccines (Basel). 2022 Jun 6;10(6):905. doi: 10.3390/vaccines10060905.
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.接种 BNT162b2 疫苗后 SARS-CoV-2 病毒载量下降的初步报告。
Nat Med. 2021 May;27(5):790-792. doi: 10.1038/s41591-021-01316-7. Epub 2021 Mar 29.
4
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.2020 年丹麦对 400 万 PCR 检测个体进行的 SARS-CoV-2 再感染保护评估：一项基于人群的观察性研究。
Lancet. 2021 Mar 27;397(10280):1204-1212. doi: 10.1016/S0140-6736(21)00575-4. Epub 2021 Mar 17.
5
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
6
Infectivity of asymptomatic versus symptomatic COVID-19.无症状与有症状的新型冠状病毒肺炎的传染性
Lancet. 2021 Jan 9;397(10269):93-94. doi: 10.1016/S0140-6736(20)32651-9. Epub 2020 Dec 18.
7
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
8
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
9
Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.在评估新型冠状病毒疫苗候选产品时，间接益处是一个关键的考量因素。
Nat Med. 2021 Jan;27(1):4-5. doi: 10.1038/s41591-020-01172-x.